Press Release

Cancer Immunotherapy Market worth 9.7% CAGR by 2026

June, 2021

" COVID-19 Impact on Flow Cytometry market, size, share, growth, industry analysis, and forecast 2020-2026 "

The treatment that uses the body’s immune system to fight cancer is known as Cancer immunotherapy. Cancer cells have the capability of invading the immune system with the help of various mechanisms. The focal point of Immunotherapy is these mechanisms and develops another mechanism to reinstate the immune system and its ability to kill the cancer cells.

Among the alternatives for cancer treatment, such as chemotherapies and radiation therapy, even though they have more adverse effects, are more vastly used than immunotherapies. All other treatments are based on killing cancer cells by irradiation, chemotherapy, or surgery. Even though they can effectively destroy or eliminate cancer cells, the adoption of these treatments is often restricted since they tend to damage the healthy cells in huge numbers. As immunotherapies include the mechanism of stimulating the body’s immunity using human-made proteins such as monoclonal antibodies, they are approved across the world over other treatment options. Thus, the rising adoption of immunotherapy treatment over other treatment options greatly enhances market growth. A few other factors that boost market growth are the rising geriatric population and the changing unfavorable lifestyles of the people.

Request for sample copy of the report @

Furthermore, the growth in the clinical trials against various types of cancers in immunotherapy and high growth potentials in the emerging countries are the factors providing lucrative opportunities for the cancer immunotherapy market growth.

The Cancer Immunotherapy Market research report titled “Cancer Immunotherapy Market by Product Type, Application, End Users and Geography – Global Forecast up to 2026.”   

Prominent players of the cancer immunotherapy market are Merck & Co., Inc., Novartis Pharmaceuticals Corporation, F. Hoffmann-La Roche AG, Advaxis Inc., and Bristol-Myers Squibb Company.

Factors such as the increasing number of patients who have cancer, growth in the adoption rate of immunotherapy, and the emergence of bioinformatics tools stimulating the drug development procedure are likely to contribute to North America's market growth North America is commanding the market.

Access full report summary @

The report consists of 97 Tables and 67 charts depicting the in-depth market study and the impact analysis of COVID-19.

Cancer Immunotherapy Market segmentation by Product Type

  • Monoclonal Antibodies
  • Cancer Vaccines
  • Check Point Inhibitors
  • Immunomodulators

Cancer Immunotherapy Market segmentation by Application

  • Lung cancer
  • Breast cancer
  • Head and neck cancer
  • Prostate cancer
  • Colorectal cancer
  • Melanoma
  • Others

Cancer Immunotherapy Market segmentation by End Users

  • Hospitals & clinic
  • Diagnostic centers

Cancer Immunotherapy Market segmentation by Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Mr. Karthick Subramani

Infoholic Research LLP

Marketing & Communication